Multimodal imaging findings in patients with glioblastoma with extensive coagulative necrosis related to regorafenib-Reference-Cited by-同舟云学术

Multimodal imaging findings in patients with glioblastoma with extensive coagulative necrosis related to regorafenib

Published:2023-03-24 Issue:6 Volume:25 Page:1193-1195
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Werner Jan-Michael¹^ORCID,Wollring Michael M¹²,Tscherpel Caroline¹²,Rosen Elena K¹,Werr Lisa³,Stetter Isabelle¹,Rueß Daniel⁴,Ruge Maximilian I⁴,Brunn Anna⁵,Al Shughri Abdulkader⁵,Kabbasch Christoph⁶,Fink Gereon R¹²,Langen Karl-Josef²⁷,Galldiks Norbert¹²⁸^ORCID

Affiliation:

1. Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne , Cologne , Germany

2. Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich , Juelich , Germany

3. Department of Experimental Pediatric Oncology, Faculty of Medicine and University Hospital Cologne, University of Cologne , Cologne , Germany

4. Department of Stereotactic and Functional Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne , Cologne , Germany

5. Institute of Neuropathology, Faculty of Medicine and University Hospital Cologne , Cologne , Germany

6. Institure of Radiology, Division of Neuroradiology, Faculty of Medicine and University Hospital Cologne, University of Cologne , Cologne , Germany

7. Department of Nuclear Medicine, University Hospital Aachen , Aachen , Germany

8. Center for Integrated Oncology (CIO), Universities of Aachen , Bonn, Cologne, and Duesseldorf, Cologne , Germany

Funder

Deutsche Forschungsgemeinschaft

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

Link

https://academic.oup.com/neuro-oncology/advance-article-pdf/doi/10.1093/neuonc/noad051/49623014/noad051.pdf

Reference10 articles.

1. Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial;Lombardi;Lancet Oncol.,2019

2. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group;Wen;J Clin Oncol.,2010

3. Advances in neuro-oncology imaging;Langen;Nat Rev Neurol.,2017

4. Immunotherapy response assessment in neuro-oncology: a report of the RANO working group;Okada;Lancet Oncol.,2015

5. Imaging findings following regorafenib in malignant gliomas: FET PET adds valuable information to anatomical MRI;Galldiks;Neurooncol Adv,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: A report of the PET/RANO group;Neuro-Oncology;2024-03-11

2. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness;Expert Reviews in Molecular Medicine;2024

3. Copper homeostasis and cuproptosis in cancer immunity and therapy;Immunological Reviews;2023-09-16